Stage 2 start of the 2011 Amgen Tour of California moved to Nevada City
Uncertain Weather Conditions Necessitate New Start Location and TimeStage 2 Start Now Scheduled for 12:15 p.m. PT in Nevada City, California
NEVADA CITY, CALIF (May 16, 2011) – Due to uncertain weather and road conditions, race organizers have determined that the best way to ensure a complete course for Stage 2 of the 2011 Amgen Tour of California is to move the official start to 12:15 p.m. PT today to a location on Broad Street in Nevada City, California. Today's start was originally scheduled to take place in Squaw Valley, California.
Following the peloton's 12:15 p.m. PT departure from Nevada City, California, the riders will travel approximately 61 miles to Sacramento, picking up the original route. The riders will enter Sacramento at approximately 3 p.m. PT and complete three circuit laps before finishing in front of the Capitol Building between 3:30 and 3:45 p.m. PT. The race's original schedule called for only one complete circuit, but due to the modified course, the additional two circuits were able to be added.
"Thanks to the quick action taken by Duane Strawser, Nevada City's 2010 local organizing committee (LOC) chairman, we were able to make this location change, allowing us a great and practical location to lead off today's race," said Andrew Messick, president of AEG Sports, presenter of the race. "Nevada City did an outstanding job hosting 2010's first stage and we know that the riders and fans will appreciate the return. We owe a debt of gratitude to Andy Chapman, Carol Chaplin and everyone in Squaw Valley, who worked tirelessly to create what would have been an exceptional Stage 2 start and hope that we will have an opportunity to bring the Amgen Tour of California to the city in a future year."
An updated Stage 2 course map and log will be posted on the official race website later this morning.
About the Amgen Tour of CaliforniaThe largest cycling event in America, the2011 Amgen Tour of Californiais a Tour de France-style cycling road race, presented by AEG, that challenges the world's top professional cycling teams to compete along a demanding course through the state from May 15-22. For more information about the Amgen Tour of California, please visit www.amgentourofcalifornia.com.
About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.
About AEGAEG is one of the leading sports and entertainment presenters in the world. AEG, a wholly owned subsidiary of The Anschutz Company, owns or controls a collection of companies including facilities such as STAPLES Center, The Home Depot Center, Sprint Center, The O2, NOKIA Theatre L.A. LIVE and NOKIA Theatre Times Square; sports franchises including the Los Angeles Kings (NHL), two Major League Soccer franchises, two hockey franchises operated in Europe, management of privately held shares of the Los Angeles Lakers, the ING Bay to Breakers foot race and the Amgen Tour of California cycling road race; AEG LIVE, the organization's live-entertainment division, is a collection of companies dedicated to all aspects of live contemporary music performance, touring and a variety of programming and multi-media production. For more information, visit AEG today at www.aegworldwide.com.
|Michael Roth||Erin Barrier|